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Filippo Rapetto1, Gustavo A. Guida1, Umberto Benedetto1 and Massimo Caputo1
1 School of Clinical Sciences, Bristol Heart Institute, University of Bristol, Bristol, UK, 2 Cardiovascular Magnetic Resonance 
Unit, NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK
Background: Surgical repair of isolated congenital tricuspid valve (TV) disease is rare 
with no well-defined indication and outcomes. Moreover, the role of right ventricle (RV) in 
this context has not yet been investigated.
Objectives: We sought to assess the impact of congenital TV repair on cardiac remod-
elling and clinical–functional status and the importance of the RV function in an adult 
congenital heart disease (ACHD) population.
Methods and results: From January 2005 to December 2015, 304 patients underwent 
TV surgery in our centre. Of these, 27 (ACHD) patients had isolated TV repair. Patients 
were evaluated with preoperative and postoperative transthoracic echocardiogram. 
Survival rate has been investigated with a mean clinical follow-up (FU) of 3.7 ± 2.3 years, 
whereas the mean echocardiographic FU was 2.9 ± 1.8 years. The clinical and func-
tional status of patients showed a statistically significant improvement after the surgical 
repair in terms of New York Heart Association class (66.7 vs 7.4%; p < 0.01), clinical 
signs of heart failure (29.6 vs 7.4%; p < 0.01), and left ventricular function (14.8 vs 7.4%; 
p < 0.01). The RV and right atrium diameter were significantly reduced after surgery 
(5.15 ± 1.21 vs 4.32 ± 1.16; p < 0.01) and (44.7 ± 16.7 vs 26.7 ± 9.2; p < 0.01), 
respectively. The degree of postoperative pulmonary hypertension was also significantly 
reduced (40.7 vs 7.4%; p < 0.01). The survival rate was 96.3% at 1 year and 93.7% at 
5 years. One patient (3.7%) had early failure of the tricuspid repair requiring a reoperation.
conclusion: Isolated TV repair for adult congenital disease significantly improved 
patients’ clinical and functional status and allowed right ventricular remodelling and 
functional improvement.
Keywords: tricuspid valve repair, adult congenital heart disease, echocardiography, right ventricular dysfunction, 
ventricular reverse remodelling
inTrODUcTiOn
Isolated severe congenital tricuspid regurgitation (TR) is an uncommon condition, most frequently 
associated with a variety of concomitant heart diseases. Regardless of the presentation, the surgical 
management is similar (1, 2). To date, a limited body of evidence is available on the outcomes of this 
subset of patients, and the published surgical guidelines are not clear in terms of surgical procedure 
and timing for surgery (3, 4). Furthermore, the negative impact of TR on long-term prognosis has 
FigUre 1 | Patient selection and exclusion criteria.
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been largely demonstrated (5), and it has been advocated that 
surgery should be considered before the development of right 
ventricle (RV) systolic dysfunction (6); in fact, these patients 
frequently have evidence of right heart failure and its concomi-
tant complications (7). Patients are rarely referred for isolated 
surgical tricuspid valve (TV) repair, and most repairs are done in 
the context of other planned cardiac operations (4). In this study, 
we sought to assess the impact of isolated TV repair on cardiac 
remodelling and clinical–functional status, and specifically its 
effect on the RV function in an adult congenital heart disease 
(ACHD) population.
MaTerials anD MeThODs
The study was conducted in accordance with the principles 
of the Declaration of Helsinki. The local audit committee 
approved the study, and the requirement for individual patient 
consent was waived.
From January 2005 to December 2015, a total of 304 adult 
patients underwent TV repair or replacement at Bristol Heart 
Institute. Patients with concomitant left heart valve diseases and/
or other cardiac congenital diseases, those who underwent TV 
replacement and those with endocarditis were excluded (Figure 1) 
from our analysis. Of these, 179 (58.8%) had a functional TR 
secondary to left heart valve failure (mitral regurgitation and/or 
aortic valve disease); 29 (9.5%) patients had TR associated with 
pulmonary valve dysfunction; 28 patients (9.2%) had isolated 
TV regurgitation secondary to endocarditis. Forty-one patients 
(13.5%) had TV replacement with prosthesis.
The remaining 27 (8.8%) were defined as ACHD patients 
undergoing surgical TV repair for isolated TR.
clinical and Functional assessment
The clinical conditions were assessed following the classifica-
tion proposed by the New York Heart Association (NYHA) and 
Canadian Cardiovascular Society (CCS). Both preoperatively 
and at the end of follow-up (FU), patients were assigned to a cor-
related class. Clinical signs and symptoms of RV failure and onset 
of newly discovered cardiac arrhythmias were regularly assessed 
during FU outpatient clinics. Short-term outcomes were derived 
from clinical notes: acute kidney injury was defined as an increase, 
during admission, of over 50% in serum creatinine compared to 
preoperative values, as previously recommended (8); acute renal 
failure was defined as the need for perioperative kidney replace-
ment therapy. Cerebrovascular accident (CVA) was defined on 
the basis of a focal or global neurological impairment at physical 
examination or at CT scan/magnetic resonance imaging. Deep 
wound infection was defined as a surgical site-related infection 
affecting the median sternotomy wound and requiring antibiotics 
and/or surgical re-exploration. Short- and long-term survival data 
TaBle 1 | Preoperative characteristics of patients with isolated tricuspid 
repair (n = 27).
characteristic Patients
Age: years 51.62 ± 14.39
Female gender 18 (66.7%)
Reduced LVEF (moderate to severe) 4 (14.7%)
RV failure (moderate to severe) 13 (48.1%)
RV dilatation 22 (81.4%)
Renal impairment 0
COPD 5 (18.5%)
Diabetes 2 (7.4%)
Hypertension 8 (29.6%)
Previous CVA 3 (11.1%)
TIA 1 (3.7%)
Smoking history
Current 0
Ex-smoker 8 (29.6%)
PVD 0
Reoperation 3 (11.1%)
Number of previous heart operations
2 1 (3.7%)
1 2 (7.4%)
Ebstein disease 14 (51.8%)
Tricuspid dysplasia 13 (48.1%)
Euro score: % 5.39 ± 8.30
Min: % 1.52
Max: % 44.82
Heart rhythm
Sinus rhythm 17 (62.9%)
AF 9 (33.3%)
AV block (paced) 1 (3.7%)
Ascites 8 (29.6%)
NYHA class 3 or 4 18 (66.7%)
CCS class 3 or 4 6 (22.2%)
Data are presented as mean ± SD, median (range), or n (%).
LVEF, left ventricular ejection fraction; RV, right ventricle; COPD, chronic obstructive 
pulmonary disease; CVA, cardiovascular accidents; TIA, transient ischaemic attack; 
PVD, peripheral vascular disease; NYHA, New York Heart Association; CCS, Canadian 
Cardiovascular Society.
Data are expressed as number of events and percentages or otherwise expressed.
TaBle 2 | Preoperative classification of congenital heart disease in 
patients with isolated tricuspid repair (n = 27).
characteristic Patients
Ebstein disease 14 (51.8%)
Non-Ebstein TR 13 (48.1%)
 – Previous congenital heart surgery in childhood
ASD
TOF
VSD
 – Tricuspid dysplasia associated PFO-small ASD
 – TV delamination defect/Ebsteinoid anomaly
3 (11.1%)
1 (3.7%)
1 (3.7%)
1 (3.7%)
4 (14.8%)
6 (22.2%)
Data are presented as mean ± SD, median (range), or n (%).
ASD, atrial septal defect; TOF, tetralogy of fallot; VSD, ventricular septal defect; TR, 
tricuspid regurgitation; PFO, patent foramen ovale; TV, tricuspid valve.
Ebsteinoid anomaly (9): variable field of disease associated with TV leaflets’ failure of 
delamination.
Data are expressed as number of events and percentages or otherwise expressed.
3
Marsico et al. Right Ventricle and TV Repair
Frontiers in Cardiovascular Medicine | www.frontiersin.org April 2017 | Volume 4 | Article 21
have been collected from the National Institute for Cardiovascular 
Outcome Research. The 30-day mortality was defined as death 
from any cause during the first 30 days following surgery.
echocardiographic evaluation
All patients underwent transthoracic echocardiography preop-
eratively, within 2 weeks after the operation and at FU. The follow-
ing parameters were assessed: left ventricular ejection fraction 
(LVEF), left ventricular internal diastolic diameter, left ventricu-
lar internal systolic diameter, thickness of the interventricular 
septum in diastole, diameter of the posterior wall, RV functional 
assessment (RV failure), right ventricular internal diastolic diam-
eter, right ventricle dilatation (RV dilatation), area of left atrium 
(LA area), area of right atrium (RA area), pulmonary artery 
pressure (PAP), grade of pulmonary hypertension, grade of TV 
regurgitation, tricuspid annular plane systolic excursion (tapse), 
and presence of haepatic veins backflow.
statistical analysis
Data are presented as mean ± 1 SD for continuous variables or as 
number and percentages for dichotomous variables. Continuous 
variables were tested for normality using the Kolmogorov–
Smirnov test and then compared between groups with unpaired 
Student’s t-test if normally distributed or Mann–Whitney U test 
if not normally distributed. In the case of dichotomous or cat-
egorical variables, Pearson chi-square or Fisher exact tests were 
used as appropriate. Overall long-term survival was estimated by 
Kaplan–Meier curve. All tests were two-sided with the alpha level 
set at 0.05 for statistical significance. The statistical analysis was 
computed using R version 3.0.2 for Windows (R Foundation for 
Statistical Computing, Vienna, Austria).
resUlTs
Patient characteristics and preoperative variables are summarised 
in Table 1. Mean age was 51.62 ± 14.4 years (range 17–73 years) 
and 18 patients (66.7%) were female. The mean clinical FU was 
3.7 ± 2.3 years, while the mean echocardiographic FU time was 
2.9 ± 1.8 years. Table 2 shows the AHDC population including 
the TV aetiopathology for each patient. Ebstein anomaly was 
diagnosed in 14 (51.8%) patients, whereas the remaining 13 
patients (48.1%) were affected by non-Ebstein tricuspid dyspla-
sia. Thirteen patients (48.1%) had right ventricular failure at the 
time of surgery and 22 (81.4%) had dilated RV. Four patients 
were found to have reduced left ventricular function (14.7%). Of 
our cohort of patients, 33.3% were diagnosed with preoperative 
atrial fibrillation, and one patient (3.7%) had a permanent pace 
maker for atrioventricular block. Ascites was present in almost 
one-third of the patients, while two-thirds of the patients were 
in NYHA class III or IV (Table 1). Mean logistic Euroscore was 
5.39 ±  8.3 and three (11.1%) patients had a previous cardiac 
surgery operation.
Intraoperative and postoperative findings are shown in Table 3. 
Nine patients (33.3%) underwent Cone procedure (http://
www.ctsnet.org/article/cone-reconstruction-tricuspid-valve-
repair-ebstein-anomaly), seven patients (25.9%) had annu-
loplasty ring and the remaining patients (40.7%) had other 
types of repair (De Vega procedure, Alfieri Stitch procedure 
and/or commissuroplasty/plication). Most patients had isolated 
TV surgery; concomitant ASD closure was performed in four 
TaBle 5 | echocardiographic evaluations of patients with isolated 
tricuspid repair (n = 27).
characteristic Preoperative Follow-up p-Value
Reduced left ventricular 
ejection fraction (mod-severe)
4 (14.8%) 2 (7.4%) <0.01
LVIDD (cm) 4.18 ± 0.79 4.34 ± 0.70 0.1
LVISD (cm) 2.76 ± 0.71 2.87 ± 0.58 0.22
IVSD (cm) 0.93 ± 0.17 0.98 ± 0.16 0.1
PWD (cm) 0.89 ± 0.13 0.94 ± 0.14 0.1
RV failure (mod-severe) 13 (48.1%) 8 (29.6%) 0.1
RV dilatation 22 (81.4%) 11 (40.7%) <0.01
Right ventricular internal 
diastolic diameter (cm)
5.15 ± 1.21 4.32 ± 1.16 <0.01
LA area (cm2) 21.3 ± 7.6 22.4 ± 8.39 0.57
RA area (cm2) 44.7 ± 16.7 26.7 ± 9.2 <0.01
Tricuspid regurgitation
Moderate 6 (22.2%) 2 (7.4%) 0.04
Severe 21(77.7%) 1 (3.7%) <0.01
Haepatic veins backflow 11(40.7%) 2 (7.4%) <0.01
PAP (mmHg) 38.91 ± 7.88 33.37 ± 5.5 0.03
TAPSE (mm) 1.91 ± 0.85 1.26 ± 0.36 <0.01
P.Hypertension (mod-severe) 11(40.7%) 2 (7.4%) <0.01
Data are presented as mean ± SD, median (range), or n (%).
LV, left ventricle; RV, right ventricle; LVIDD, left ventricular internal dimension in diastole; 
LVISD, left ventricular internal end-systolic dimension; IVSD, interventricular septum 
in diastole; PWD, posterior wall dimensions; RV, right ventricle; LA, left atrium; RA, 
right atrium; PAP, pulmonary arterial pressure; TAPSE, tricuspid annular plane systolic 
excursion; P.Hypertension, pulmonary hypertension.
Data are expressed as number of events and percentages or otherwise expressed.
TaBle 4 | clinical and functional assessment of patients with isolated 
tricuspid repair (n = 27).
characteristic Preoperative Follow-up p-Value
NYHA 3–4 18 (66.7%) 2 (7.4%) <0.01
CCS high class 6 (22.2%) 1 (3.7%) <0.01
Heart rhythm
NSR 17 (62.9%) 18 (74%) 0.1
AF 9 (33.3%) 8 (29.6%) 0.1
Paced 1 (3.7%) 1 (3.7%) 0.1
Ascites p. oedema 8 (29.6%) 2 (7.4%) <0.01
Data are presented as mean ± SD, median (range), or n (%).
NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; NSR, 
normal sinus rhythm; AF, atrial fibrillation.
Data are expressed as number of events and percentages or otherwise expressed.
TaBle 3 | Operative and postoperative characteristics of patients with 
isolated tricuspid repair (n = 27).
characteristic Patients
Tricuspid valve procedure
Cone 9 (33.3%)
Annuloplasty ring 7 (25.9%)
Alfieri–plication–commissuroplasty 3 (11.1%)
Others 8 (29.6%)
PFO-small ASD closure 4 (14.8%)
MAZE 4 (14.8%)
CPB time (min) 104.96 ± 44.72
Cross-clamp time (min) 66.29 ± 32.41
Return to theatre 1 (3.7%)
Repair failure 1 (3.7%)
Deep wound infection 1 (3.7%)
New CVA 0
Post op dialysis 0
Length of hospital stay (days) 14.59 ± 11.30
Min (days) 5
Max (days) 53
Data are presented as mean ± SD, median (range), or n (%).
PFO, patent foramen ovale; ASD, atrial septal defect; CPB, cardio pulmonary bypass; 
CVA, cardiovascular accidents.
Data are expressed as number of events and percentages or otherwise expressed.
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(14.8%) patients; antiarrhythmic surgery such as MAZE procedure 
was also performed in four (14.8%) patients. Mean cardiopulmo-
nary bypass time was 104.9 ± 44.7 min, and mean cross-clamp 
time was 66.3  ±  32.4  min. In one case (3.7%), with Ebstein 
disorder, it was necessary to re-operate during the postoperative 
course for failure of TV repair; this patient eventually underwent 
TV replacement. One patient (3.7%) suffered a postoperative 
deep wound infection (mediastinitis), which required surgical 
re-exploration: this condition deteriorated to postoperative 
sepsis and subsequent death. No patient experienced episodes of 
cerebral ischaemia (CVA) or renal impairment in the periopera-
tive period.
Follow-up
Clinical and Functional Results
The clinical and functional status of patients assessed accord-
ing to the NYHA and CCS classification shows a statistically 
significant improvement: 66.7% patients in NYHA class III-IV 
preoperatively vs 7.4% at FU (p < 0.01) and 22.2% in CCS class 
III–IV preoperatively vs 3.7% at FU (p < 0.01). Also, our study 
demonstrated a significant reduction of clinical signs of heart 
failure such as ascites and peripheral oedema (29.6 vs 7.4%; 
p < 0.01). These data are shown in Table 4.
Echocardiographic Evaluations
Table  5 shows the preoperative and postoperative echocardio-
graphic evaluation, with a mean FU echocardiographic time of 
2.9 ±  1.8  years. There was a marked improvement in left ven-
tricular function (14.8 vs 7.4%; p <  0.01), while no significant 
differences were found regard to the left ventricular diameters 
and wall thickness. Similarly, no significant differences were 
found concerning the left atrial volumes. At FU, all patients 
showed a significant reduction in right ventricular diameters 
(5.15 ± 1.21 vs 4.32 ± 1.16 cm; p < 0.01). We also observed a 
different remodelling in right atrial geometry (44.7 ±  16.7 vs 
26.7 ± 9.2 cm2; p < 0.01). Regarding the functionality of TV, a 
clear reduction of valvular regurgitation has been observed at FU. 
Furthermore, TR significantly improved both in patients with 
moderate (22.2 vs 7.4%; p = 0.04) and severe baseline TR (77.7 vs 
3.7%; p < 0.01). In addition, the pulmonary pressure (38.9 ± 7.8 
vs 33.3 ±  5.5  mmHg; p =  0.03) and the degree of pulmonary 
hypertension (40.7 vs 7.4%; p < 0.01) were significantly reduced. 
A net reduction was also noticed in the number of patients with 
haepatic veins backflow (40.7 vs 7.4%; p < 0.01). On the other 
hand, TAPSE values dropped significantly in this period of evalu-
ation (1.9 ± 0.85 vs 1.2 ± 0.36 mm; p < 0.01).
In Table  6, we reported the results of a sub-analysis that 
was conducted on the preoperative and postoperative echocar-
diographic evaluation in the Ebstein population. A significant 
TaBle 6 | echocardiographic evaluations of patients with isolated 
tricuspid repair, subset analysis in ebstein population (n = 14).
characteristic Preoperative Follow-up p-Value
Reduced left ventricular ejection 
fraction (mod-severe)
2 (14.3%) 0 NA
LVIDD (cm) 3.64 ± 0.4 4.0 ± 0.50 0.01
LVISD (cm) 2.41 ± 0.49 2.59 ± 0.43 0.09
IVSD (cm) 0.87 ± 0.18 0.92 ± 0.11 0.28
PWD (cm) 0.88 ± 0.13 0.91 ± 0.11 0.53
RV failure (mod-severe) 7 (50%) 2 (14.3%) 0.47
RV dilatation 14 (100%) 6 (42.8%) <0.01
Right ventricular internal diastolic 
diameter (cm)
5.54 ± 1.17 4.28 ± 1.08 0.03
LA area (cm2) 17.3 ± 1.9 19.6 ± 6.5 0.29
RA area (cm2) 48.3 ± 11.2 26.0 ± 10.5 <0.01
Tricuspid regurgitation
Severe 14 (100%) 0 NA
Haepatic veins backflow 6(42.8%) 2 (14.3%) 0.47
PAP (mmHg) 37.8 ± 5.05 33.3 ± 3.9 0.06
TAPSE (mm) 2.2 ± 1.04 1.35 ± 0.39 <0.01
P.Hypertension (mod-severe) 7(50%) 2 (14.3%) <0.48
Data are presented as mean ± SD, median (range), or n (%).
LV, left ventricle; RV, right ventricle; LVIDD, left ventricular internal dimension in diastole; 
LVISD, left ventricular internal end-systolic dimension; IVSD, interventricular septum 
in diastole; PWD, posterior wall dimensions; RV, right ventricle; LA, left atrium; RA, 
right atrium; PAP, pulmonary arterial pressure; TAPSE, tricuspid annular plane systolic 
excursion; P.Hypertension, pulmonary hypertension.
Data are expressed as number of events and percentages or otherwise expressed.
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improvement was found in left ventricular function and on the 
left ventricular diameters (3.64 ± 0.4 vs 4.0 ± 0.5 cm; p = 0.01) 
without supplementary modification of wall thickness.
Similar to the main analysis, this sub group showed a sub-
stantial reduction in right ventricular diameters (5.54 ±  1.17 
vs 4.28 ± 1.08 cm; p = 0.03) and RV dilatation (100 vs 42.8%; 
p < 0.01).
An interesting reduction has been observed on right atrial area 
(48.3 ± 11.2 vs 26 ± 10.5 cm2; p < 0.01). Furthermore, the Ebstein 
population also showed a visible reduction of valvular regurgita-
tion between the preoperative and the FU (100 vs 0%; p: NA). In 
addition, TAPSE values were considerably reduced (2.2 ± 1.04 vs 
1.35 ± 0.39 mm; p < 0.01).
Survival
Figure 2 reports the survival after surgery. Early mortality shows 
that one patient (3.7%) died during the admission due to infec-
tion of the surgical site (mediastinitis). One patient died, during 
the FU, from non-cardiac related disease (neoplastic disease). The 
long-term survival was 96.3% at 1 year and 93.7% at 5 years.
All but one patient remained free from reoperation during 
the FU.
DiscUssiOn
The incidence of isolated TR among congenital heart disease 
patients is quite rare, being reported approximately around 
1–2% in the Dutch nationwide Congenital Corvitia registry (10). 
Although previously long underappreciated, TV disease is 
nowadays receiving increasing attention. However, guidelines for 
surgical management of tricuspid disease are less aggressive and 
more subjective than those related to left-sided cardiac valves 
(3, 11), thus implying that the indications to surgical interven-
tion and methods of approach and repair are not uniform across 
institutions (7, 12, 13). Interestingly, some studies report no 
significant differences in outcome among the different surgical 
strategies (2), whereas other series showed better outcomes of 
repair vs replacement (1).
Congenital TV disease requiring surgical correction remains 
a rare entity: we found that, of the TV operations performed over 
10  years at our institute, primary isolated tricuspid disease in 
ACHD patients represented only 8.8% of cases. Previous clinical 
reports suggest that surgery is beneficial in terms of improve-
ments of symptoms and functional status (6). As reported by 
Nath et al. (5), improvement in TR severity, regardless of LVEF 
or PAP, is associated with better survival, while the presence of 
a severe TR is associated with a poor prognosis (6). Our results 
showed a significant reduction of TV regurgitation at FU with 
consequent reduction in haepatic veins flow and mean PAP. 
Furthermore, patients had a significant improvement in clinical 
status and reduction of clinical signs of heart failure, thus leading 
to a significant improvement in quality of life. These findings are 
in keeping with previous reports showing clinical improvements 
after TV repair as described by Kim et al. (6).
The 30-day mortality rate also appears to be low in our series 
(2): one patient died of a surgery-related cause while another 
patient had a non-cardiac-related death: similar results were 
demonstrated by previous studies where the operative mortal-
ity rate was calculated at 4% (14). The mid-term and long-term 
survival rates are also reassuring.
The optimal timing for surgical intervention is still debated 
(10, 15), but in daily practice patients are referred to surgery 
mainly because of symptoms secondary to RV impairment 
(1, 10, 15). Our findings were consistent with these data, as 
patients were referred to surgery at a late stage in the disease 
course, when highly symptomatic: more than two thirds (67%) 
were in NYHA class III or IV and clinical signs of right heart 
failure were reported in 30% of patients. RV failure was reported 
in 48% of patients and RV dilatation in 81%. Surgical intervention 
had a significant impact on the remodelling of the RV as shown 
in our 3-year FU. Echocardiography showed a reduction in RV 
dimensions (5.15 ± 1.2 vs 4.32 ± 1.16 cm; p < 0.01), and RA area 
(44.7 ± 16.7 vs 26.7 ± 9.2 cm2; p < 0.01); this is most likely due to 
the effect of reduced RV pre-load. On the other hand, there was 
no significant change in RV function (p = 0.1); this is probably 
due to advanced structural modification of the RV which may 
have occurred before the time of the surgery (16). Therefore, the 
timing of surgery may be crucial to prevent damage to the RV and 
to achieve better results in the long term.
Annular repair also leads to increased stability of the cardiac 
skeleton, which might partially explain the reduction of the 
TAPSE at FU (1.91 ± 0.85 vs 1.26 ± 0.36 cm; p < 0.01).
There was a marked improvement in left ventricular function 
(14.8 vs 7.4%; p <  0.01) despite there being no changes in the 
left ventricular diameters and wall thickness; possibly due to a 
reduction of volume of the RV which decreases the compression 
on the left ventricle.
FigUre 2 | Kaplan–Meier survival curves for patients with tricuspid regurgitation after tricuspid valve repair.
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After performing a sub-analysis of the echocardiographic 
findings in the Ebstein disease group, we have interestingly noted 
that the FU findings were in keeping with the results of the whole 
population analysed.
The incidence of arrhythmia did not change at FU (p < 0.1), 
strengthening the idea that structural damage is a non-reversible 
phenomenon. As reported in the literature, AF has been recog-
nised as an objective predictor of survival, rising mortality and 
morbidity due to thromboembolism risk and heart failure (17), 
making the argument that indication for surgery should be based 
on RV volumes and function, and leading to surgical intervention 
before RV failure (6, 12). The right cavities overload reduction 
leads to a significant clinical benefit, freedom from symptoms and 
signs of heart failure, and an improvement in quality of life.
For these reasons, we believe that surgical treatment of TR in 
congenital heart disease should be performed before the onset of 
heart failure. This concept has already been supported by other 
studies (1, 2, 6, 12).
Among the cohort of ACHD patients, the RV has also been 
defined as “forgotten” (12), even though, in the last decade, 
increasing attention has been focussed on it, in an effort to avoid 
the adverse outcomes associated with its dysfunction and fibrosis 
(16). These include not only exercise limitation but also malignant 
ventricular arrhythmias (17). In various clinical scenarios, TV 
surgery, as well as pulmonary surgery, is performed earlier in an 
attempt to “save” the RV, and the surgical mortality in experienced 
centres is acceptably low (12, 18).
As reported by Warnes (12), the conventional echocardio-
graphic evaluations focussed on the functional assessment of the 
RV are very challenging because of its complex structure. In 
contrast, Cardiac Magnetic Resonance and the improved 3D 
echocardiographic imaging offer better evaluation of the right 
chambers of the heart (19–21). For these reasons, ACHD should 
be referred to specific centres in which adequate imaging and 
better understanding of the pathology can improve assessment 
and optimise surgical timing when appropriate.
Our study is a retrospective analysis of a relatively small cohort 
of patients, due to the rarity of isolated TR in ACHD, further 
multi-centric studies on a larger population should be performed 
to confirm and expand our findings. The cohort of analysis of 
this study is also too small to draw a conclusion on long-term 
re-TV rate.
cOnclUsiOn
Tricuspid valve repair is efficient and durable for the majority of 
patients with isolated TV regurgitation.
The medium and long-term evaluation show good results on 
durability and functionality.
When operated at optimal timing, TV repair allows a vol-
ume reduction of right cavities associated with both atrial and 
ventricular reverse remodelling at long-term FU. This condition 
leads to an improvement in quality of life due to the freedom from 
symptoms of heart failure.
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However, in ACHD populations, these benefits are mostly 
represented when TV repair intervenes once RV structural dam-
age has not already occurred.
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